BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 24654803)

  • 1. Susceptibility quantitative trait loci for pathogenic leucocytosis in SCG/Kj mice, a spontaneously occurring crescentic glomerulonephritis and vasculitis model.
    Hamano Y; Abe M; Matsuoka S; Zhang D; Kondo Y; Kagami Y; Ishigami A; Maruyama N; Tsuruta Y; Yumura W; Suzuki K
    Clin Exp Immunol; 2014 Jul; 177(1):353-65. PubMed ID: 24654803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vasculitis and crescentic glomerulonephritis in a newly established congenic mouse strain derived from ANCA-associated vasculitis-prone SCG/Kj mice.
    Hamano Y; Ito F; Suzuki O; Koura M; Matsuoka S; Kobayashi T; Sugitani Y; Wali N; Koyanagi A; Hino O; Suzuki S; Sugamata R; Yoshizawa H; Yumura W; Maruyama N; Kameoka Y; Noda Y; Hasegawa Y; Arai T; Suzuki K
    Autoimmunity; 2019; 52(5-6):208-219. PubMed ID: 31476889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic dissection of vasculitis, myeloperoxidase-specific antineutrophil cytoplasmic autoantibody production, and related traits in spontaneous crescentic glomerulonephritis-forming/Kinjoh mice.
    Hamano Y; Tsukamoto K; Abe M; Sun GD; Zhang D; Fujii H; Matsuoka S; Tanaka M; Ishida-Okawara A; Tachikawa H; Nishimura H; Tokunaka K; Hirose S; Suzuki K
    J Immunol; 2006 Mar; 176(6):3662-73. PubMed ID: 16517735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SCG/Kinjoh mice: a model of ANCA-associated crescentic glomerulonephritis with immune deposits.
    Neumann I; Birck R; Newman M; Schnülle P; Kriz W; Nemoto K; Yard B; Waldherr R; Van Der Woude FJ
    Kidney Int; 2003 Jul; 64(1):140-8. PubMed ID: 12787404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutrophil contribution to the crescentic glomerulonephritis in SCG/Kj mice.
    Ishida-Okawara A; Ito-Ihara T; Muso E; Ono T; Saiga K; Nemoto K; Suzuki K
    Nephrol Dial Transplant; 2004 Jul; 19(7):1708-15. PubMed ID: 15150352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of interleukin-6 and monocyte chemotactic protein-1 concentrations with crescent formation and myeloperoxidase-specific anti-neutrophil cytoplasmic antibody titer in SCG/Kj mice by treatment with anti-interleukin-6 receptor antibody or mizoribine.
    Nagao T; Kusunoki R; Iwamura C; Kobayashi S; Yumura W; Kameoka Y; Nakayama T; Suzuki K
    Microbiol Immunol; 2013 Sep; 57(9):640-50. PubMed ID: 23829825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of MPO-ANCA epitopes in SCG/Kj mice by 15-deoxyspergualin treatment restricted by IgG2b associated with crescentic glomerulonephritis.
    Tomizawa K; Nagao T; Kusunoki R; Saiga K; Oshima M; Kobayashi K; Nakayama T; Tanokura M; Suzuki K
    Rheumatology (Oxford); 2010 Jul; 49(7):1245-56. PubMed ID: 20378710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic selection for crescent formation yields mouse strain with rapidly progressive glomerulonephritis and small vessel vasculitis.
    Kinjoh K; Kyogoku M; Good RA
    Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3413-7. PubMed ID: 8475090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the ameliorative effects of immunosuppressants on crescentic glomerulonephritis in SCG/Kj mice.
    Saiga K; Yoshida M; Nakamura I; Toyoda E; Tokunaka K; Morohashi H; Abe F; Nemoto K; Nose M
    Int Immunopharmacol; 2008 Sep; 8(9):1183-9. PubMed ID: 18602063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myeloperoxidase-antineutrophil cytoplasmic antibody-associated crescentic glomerulonephritis with rheumatoid arthritis: a comparison of patients without rheumatoid arthritis.
    Kurita N; Mise N; Fujii A; Mori M; Sai K; Nishi T; Suzuki T; Tagawa H; Sugimoto T
    Clin Exp Nephrol; 2010 Aug; 14(4):325-32. PubMed ID: 20339893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trafficking of QD-conjugated MPO-ANCA in murine systemic vasculitis and glomerulonephritis model mice.
    Hoshino A; Nagao T; Ito-Ihara T; Ishida-Okawara A; Uno K; Muso E; Nagi-Miura N; Ohno N; Tokunaka K; Naoe S; Hashimoto H; Yasuhara M; Yamamoto K; Suzuki K
    Microbiol Immunol; 2007; 51(5):551-66. PubMed ID: 17579266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice.
    Xiao H; Heeringa P; Hu P; Liu Z; Zhao M; Aratani Y; Maeda N; Falk RJ; Jennette JC
    J Clin Invest; 2002 Oct; 110(7):955-63. PubMed ID: 12370273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-neutrophil cytoplasmic antibodies and effector CD4+ cells play nonredundant roles in anti-myeloperoxidase crescentic glomerulonephritis.
    Ruth AJ; Kitching AR; Kwan RY; Odobasic D; Ooi JD; Timoshanko JR; Hickey MJ; Holdsworth SR
    J Am Soc Nephrol; 2006 Jul; 17(7):1940-9. PubMed ID: 16769746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetically determined severity of anti-myeloperoxidase glomerulonephritis.
    Xiao H; Ciavatta D; Aylor DL; Hu P; de Villena FP; Falk RJ; Jennette JC
    Am J Pathol; 2013 Apr; 182(4):1219-26. PubMed ID: 23384999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of crescentic glomerulonephritis in SCG/Kj mice by bone marrow transplantation.
    Cherry ; Engelman RW; Wang BY; Kinjoh K; El-Badri NS; Good RA
    Proc Soc Exp Biol Med; 1998 Jul; 218(3):223-8. PubMed ID: 9648940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anti-neutrophil cytoplasmic antibody MPO-ANCA related with disease activity of vasculitis].
    Suzuki K
    Nihon Rinsho Meneki Gakkai Kaishi; 2006 Apr; 29(2):94-101. PubMed ID: 16651707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone marrow-derived cells are sufficient and necessary targets to mediate glomerulonephritis and vasculitis induced by anti-myeloperoxidase antibodies.
    Schreiber A; Xiao H; Falk RJ; Jennette JC
    J Am Soc Nephrol; 2006 Dec; 17(12):3355-64. PubMed ID: 17108314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-endothelial cell antibodies in antineutrophil cytoplasmic antibodies negative pauci-immune crescentic glomerulonephritis.
    Cong M; Chen M; Zhang JJ; Hu Z; Zhao MH
    Nephrology (Carlton); 2008 Jun; 13(3):228-34. PubMed ID: 18315705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic Myeloperoxidase Inhibition Attenuates Neutrophil Activation, ANCA-Mediated Endothelial Damage, and Crescentic GN.
    Antonelou M; Michaëlsson E; Evans RDR; Wang CJ; Henderson SR; Walker LSK; Unwin RJ; Salama AD;
    J Am Soc Nephrol; 2020 Feb; 31(2):350-364. PubMed ID: 31879336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coexistence of anti-GBM antibodies and MPO-ANCA in a patient with systemic vasculitis and crescentic glomerulonephritis.
    Fernandes P; Lopes JA; Correia L; Gonçalves S; Jorge S
    Nefrologia; 2010; 30(6):709-10. PubMed ID: 21113229
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.